| __timestamp | Bausch Health Companies Inc. | Novo Nordisk A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 26760000000 |
| Thursday, January 1, 2015 | 2682700000 | 32169000000 |
| Friday, January 1, 2016 | 2810000000 | 32339000000 |
| Sunday, January 1, 2017 | 2582000000 | 32124000000 |
| Monday, January 1, 2018 | 2473000000 | 33313000000 |
| Tuesday, January 1, 2019 | 2554000000 | 35830000000 |
| Wednesday, January 1, 2020 | 2367000000 | 36886000000 |
| Friday, January 1, 2021 | 2624000000 | 41058000000 |
| Saturday, January 1, 2022 | 2625000000 | 50684000000 |
| Sunday, January 1, 2023 | 2917000000 | 61598000000 |
| Monday, January 1, 2024 | 67377000000 |
Data in motion
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Novo Nordisk A/S and Bausch Health Companies Inc. have taken different paths in optimizing these costs. From 2014 to 2023, Novo Nordisk's SG&A expenses have surged by approximately 130%, reflecting its aggressive expansion and marketing strategies. In contrast, Bausch Health has maintained a more stable trajectory, with a modest increase of around 44% over the same period.
Novo Nordisk's significant rise in SG&A expenses, peaking at over $61 billion in 2023, underscores its commitment to global market penetration. Meanwhile, Bausch Health's expenses, reaching nearly $3 billion, highlight a more conservative approach. This divergence in strategy offers a fascinating insight into how these industry giants balance growth and cost efficiency.
Eli Lilly and Company and Novo Nordisk A/S: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or United Therapeutics Corporation
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or Alkermes plc
Breaking Down SG&A Expenses: Novo Nordisk A/S vs ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: Johnson & Johnson vs Bausch Health Companies Inc. Trends and Insights
Blueprint Medicines Corporation and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Corcept Therapeutics Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Alpine Immune Sciences, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Bausch Health Companies Inc. vs ImmunityBio, Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Bausch Health Companies Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared